For instance, one such non-peptide-based GLP-1RA formulation, called Orforglipron (LY3502970), has been developed and is currently undergoing Phase III clinical trials (Wharton et al., 2025
PlexusDx compounded tirzepatide is available from licensed 503A pharmacies and is $289/mo month-to-month, or from $249/mo on the 6-month plan with transparent, dose-independent pricing
Your provider will help determine whether it fits your needs, and how it may be combined with other peptides, lifestyle strategies, and therapies for a more complete plan
It helps to calm skin irritation by reducing the levels of pro-inflammatory cytokines, which are chemical messengers that contribute to redness and swelling
Clostridium Butyricum: The Butyrate Producer Clostridium butyricum is a probiotic strain that produces butyrate, a short-chain fatty acid with metabolic effects
FDA banned it in late 2023 "Category 2: Substance with Safety Concerns" Why the FDA banned it: Potential immune reactions (immunogenicity) Manufacturing impurities in compounded versions Complete lack of human safety data Risk of contamination Legal status: NOT FDA-approved Illegal to compound in pharmacies Banned by WADA for athletes Possession not illegal (it's not a DEA scheduled substance) Sold online as "research chemical" 2
